Neisseria gonorrhoeae antimicrobial susceptibility in Lilongwe, Malawi, 2007

Sexually Transmitted Diseases

Volumn 37, Issue 3, 2010, Pages 169-172

  Brown, Lillian B ^a,b   Krysiak, Robert ^a,b   Kamanga, Gift ^b   Mapanje, Clemente ^b   Kanyamula, Happiness ^b   Banda, Blessings ^b   Mhango, Chisale ^c   Hoffman, Mariah ^b   Kamwendo, Debbie ^b   Hobbs, Marcia ^a   Hosseinipour, Mina C ^a   Martinson, Francis ^b   Cohen, Myron S ^a   Hoffman, Irving F ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA PROJECT   (Malawi)

^c MINISTRY OF HEALTH   (Malawi)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFIXIME; CEFTRIAXONE; CIPROFLOXACIN; DOXYCYCLINE; GENTAMICIN; PENICILLIN G; SPECTINOMYCIN; TETRACYCLINE;

ADULT; AGAR DILUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; DISK DIFFUSION; DRUG EFFICACY; EPSILOMETER TEST; GONORRHEA; GRAM STAINING; HUMAN; MAJOR CLINICAL STUDY; MALAWI; MALE; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; PRACTICE GUIDELINE; SEXUALLY TRANSMITTED DISEASE; THROAT CULTURE; URETHRA; URETHRITIS; UROGENITAL SYSTEM EXAMINATION;

ANTI-BACTERIAL AGENTS; DOXYCYCLINE; GENTAMICINS; GONORRHEA; HUMANS; MALAWI; MALE; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE; SYNDROME; URETHRITIS;

EID: 77649123172     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3181bf575c     Document Type: Article

References (31)

1. World Health Organization. Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections. Geneva Switzerland: WHO; 2001.
2. Laga M, Manoka A, Kivuvu M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: Results from a cohort study. AIDS 1993; 7:95-102.
3. Zhang J, Li G, Bafica A, et al. Neisseria gonorrhoeae enhances infection of dendritic cells by HIV type 1. J Immunol 2005; 174:7995-8002.
4. Chen A, Boulton IC, Pongoski J, et al. Induction of HIV-1 long terminal repeat-mediated transcription by Neisseria gonorrhoeae. AIDS 2003; 17:625-628.
5. Cohen MS, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: Implications for prevention of sexual transmission of HIV-1. Lancet 1997; 349:1868-1875.
6. Workowski K, Berman M, Douglas J. Emerging antimicrobial resistance in Neisseria gonorrhoeae: Urgent need to strengthen prevention strategies. Ann Intern Med 2008; 148:606-613
7. WHO. Management of sexually transmitted diseases. Document WHO/GPA/TEM94.1 Rev. 1. Geneva, Switzerland: World Health Organization; 1997.
8. Apalata T, Zimba TF, Sturm WA, et al. Antimicrobial susceptibility profile of Neisseria gonorrhoeae isolated from patients attending a STD facility in Maputo, Mozambique. Sex Transm Dis 2009; 36:341-343.
9. Cao V, Ratsima E, Van Tri D, et al. Antimicrobial susceptibility of Neisseria gonorrhoeae strains isolated in 2004-2006 in Bangui, Central African Republic; Yaounde, Cameroon; Antananarivo, Madagascar; and Ho Chi Minh Ville and Nha Trang, Vietnam. Sex Transm Dis 2008; 35:941-945.
10. Mbwana J, Mhalu F, Mwakagile D, et al. Susceptibility pattern of Neisseria gonorrhoeae to antimicrobial agents in Dar es Salaam. East Afr Med J 1999; 76:330-334.
11. Tadesse A, Mekonnen A, Kassu A, et al. Antimicrobial sensitivity of Neisseria gonorrhoeae in Gondar, Ethiopia. East Afr Med J 2001; 78:259-261.
12. Van Dyck E, Karita E, Abdellati S, et al. Antimicrobial susceptibilities of Neisseria gonorrhoeae in Kigali, Rwanda, and trends of resistance between 1986 and 2000. Sex Transm Dis 2001; 28:539-545.
13. Management of Sexually Transmitted Infections Using Syn-dromic Management Approach: Guidelines for Service Providers. Lilongwe, Malawi: Malawi Ministry of Health; 2007.
14. Lule G, Behets FM, Hoffman IF, et al. STD/HIV control in Malawi and the search for affordable and effective urethritis therapy: A first field evaluation. Genitourin Med 1994; 70:384-388.
15. Daly CC, Hoffman I, Hobbs M, et al. Development of an antimicrobial susceptibility surveillance system for Neisseria gonor-rhoeae in Malawi: Comparison of methods. J Clin Microbiol 1997; 35:2985-2988.
16. Price MA, Zimba D, Hoffman IF, et al. Addition of treatment for trichomoniasis to syndromic management of urethritis in Malawi: A randomized clinical trial. Sex Transm Dis 2003; 30:516-522.
17. Taha TE, Brown ER, Hoffman IF, et al. A phase III clinical trial of antibiotics to reduce chorioamnionitis-related perinatal HIV-1 transmission. AIDS 2006; 20:1313-1321.
18. CLSI. Performance standards for antimicrobial susceptibility testing. 15th Informational supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2005.
19. CDC B88. Neisseria Gonorrheae Reference Strains for Antimicrobial Susceptibility Testing. Atlanta, GA: Centers for Disease Control and Prevention; 2005.
20. Brown L, Krysiak R, Kamanga G, et al. HIV testing and Neisseria gonorrhoeae antimicrobial susceptibility among men with ure-thritis in Lilongwe, Malawi. In: XVII International AIDS Conference; 2008; Mexico City. Abstract no MOPE0379.
21. Hobbs M, Kazembe P, Reed AW, et al. Trichomonas vaginalis as a cause of urethritis in Malawian men. Sex Transm Dis 1999; 26:381-387.
22. Ieven M, Van Looveren M, Sudigdoadi S, et al. Antimicrobial susceptibilities of Neisseria gonorrhoeae strains isolated in Java, Indonesia. Sex Transm Dis 2003; 30:25-29.
23. Joesoef MR, Knapp JS, Idajadi A, et al. Antimicrobial susceptibilities of Neisseria gonorrhoeae strains isolated in Surabaya, Indonesia. Antimicrob Agents Chemother 1994; 38:2530-2533.
24. Lesmana M, Lebron CI, Taslim D, et al. In vitro antibiotic susceptibility of Neisseria gonorrhoeae in Jakarta, Indonesia. Antimicrob Agents Chemother 2001; 45:359-362.
25. Sutrisna A, Soebjakto O, Wignall FS, et al. Increasing resistance to ciprofloxacin and other antibiotics in Neisseria gonorrhoeae from East Java and Papua, Indonesia, in 2004-implications for treatment. Int J STD AIDS 2006; 17:810-812.
26. Moodley P, Sturm AW. Ciprofloxacin-resistant gonorrhoeae in South Africa. Lancet 2005; 366:1159.
27. Lewis DA, Scott L, Slabbert M, et al. Escalation in the relative prevalence of ciprofloxacin-resistant gonorrhoeae among men with urethral discharge in two South African cities: Association with HIV seropositivity. Sex Transm Infect 2008; 84:352-355.
28. Van Dyck E, Smet H, Piot P. Comparison of E test with agar dilution for antimicrobial susceptibility testing of Neisseria gon-orrhoeae. J Clin Microbiol 1994; 32:1586-1588.
29. Unemo M, Fasth O, Fredlund H, et al. Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes. J Antimicrob Chemother 2009; 63:1142-1151.
30. Malawi Demographic and Health Survey 2004. Calverton, MD: National Statistical Office (Malawi) and ORC Macro; 2005.
31. Tapsall J. Antibiotic Resistance in Neisseria gonorrhoeae. Clin Infect Dis 2005; 41(suppl 4):S263-S268.